BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Clinical trial NCT00397501 · WITHDRAWN

Trial details

NCT number: NCT00397501
Sponsor: OHSU Knight Cancer Institute
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Breast Cancer Cognitive/Functional Effects Drug/Agent Toxicity by Tissue/Organ Psychosocial Effects of Cancer and Its Treatment

Start date: 2013-10-01
Primary completion: 2013-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.